Skip to main content

Quantessence Capital LLC

SEC CIK
0002009590
Latest filing
Aug 14, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Quantessence Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2025
Holdings of BCRX by Quantessence Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−13,200−100.0%Sold outHolders
Q4 202513,200$103.0K1.2%+13,200NewHolders